Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2020 Oct 15;75(11):2169-2176.
doi: 10.1093/gerona/glaa129.

Orthostatic Blood Pressure Recovery Is Associated With the Rate of Cognitive Decline and Mortality in Clinical Alzheimer's Disease

Affiliations
Randomized Controlled Trial

Orthostatic Blood Pressure Recovery Is Associated With the Rate of Cognitive Decline and Mortality in Clinical Alzheimer's Disease

Rianne A A de Heus et al. J Gerontol A Biol Sci Med Sci. .

Abstract

Background: Impaired recovery of blood pressure (BP) after standing has been shown to be related to cognitive function and mortality in people without dementia, but its role in people with Alzheimer's disease (AD) is unknown. The aim of this study was to investigate the association of the orthostatic BP response with cognitive decline and mortality in AD.

Methods: In this post hoc analysis of a randomized controlled trial (Nilvad), we measured the beat-to-beat response of BP upon active standing in mild-to-moderate AD. This included the initial drop (nadir within 40 seconds) and recovery after 1 minute, both expressed relative to resting values. We examined the relationship between a small or large initial drop (median split) and unimpaired (≥100%) or impaired recovery (<100%) with 1.5-year change in Alzheimer's Disease Assessment-cognitive subscale (ADAS-cog) scores and all-cause mortality.

Results: We included 55 participants (age 73.1 ± 6.2 years). Impaired BP recovery was associated with higher increases in ADAS-cog scores (systolic: β [95% confidence interval] = 5.6 [0.4-10.8], p = .035; diastolic: 7.6 [2.3-13.0], p = .006). During a median follow-up time of 49 months, 20 participants died. Impaired BP recovery was associated with increased mortality (systolic: HR [95% confidence interval] = 2.9 [1.1-7.8], p = .039; diastolic: HR [95% confidence interval] = 5.5 [1.9-16.1], p = .002). The initial BP drop was not associated with any outcome. Results were adjusted for age, sex, and intervention group.

Conclusions: Failure to fully recover BP after 1 minute of standing is associated with cognitive decline and mortality in AD. As such, BP recovery can be regarded as an easily obtained marker of progression rate of AD.

Keywords: Alzheimer’s disease; Blood pressure; Continuous monitoring; Dementia; Resilience.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Orthostatic challenge response for fast progressors (n = 18, black lines) and others (n = 33, gray lines). (A) Systolic blood pressure (SBP). (B) Diastolic blood pressure (DBP). Fast progressors were those with an Alzheimer’s Disease Assessment—cognitive subscale (ADAS-cog) increase of ≥12 points (n = 13) or who progressed too severely to perform the ADAS-cog at follow-up (n = 5). Unfiltered results are presented with a sample frequency of 10 Hz. Results of three trials within an individual are averaged.
Figure 2.
Figure 2.
Prolonged orthostatic challenge response for fast progressors (n = 17, black lines) and others (n = 31, gray lines). (A) Systolic blood pressure (SBP). (B) Diastolic blood pressure (DBP). Fast progressors were those with an Alzheimer’s Disease Assessment—cognitive subscale (ADAS-cog) increase of ≥12 points (n = 13) or who progressed too severely to perform the ADAS-cog at follow-up (n = 4). Filtered results are presented with a sample frequency of 10 Hz.
Figure 3.
Figure 3.
Cox proportional hazards adjusted cumulative survival curves for unimpaired versus impaired systolic and diastolic blood pressure recovery after 1 min of standing. Adjusted for age, sex, and intervention group.

Similar articles

Cited by

References

    1. Melis RJF, Haaksma ML, Muniz-Terrera G. Understanding and predicting the longitudinal course of dementia. Curr Opin Psychiatry. 2019;32:123–129. doi:10.1097/YCO.0000000000000482 - DOI - PMC - PubMed
    1. Haaksma ML, Rizzuto D, Leoutsakos JS, et al. Predicting cognitive and functional trajectories in people with late-onset dementia: 2 population-based studies. J Am Med Dir Assoc. 2019;20:1444–1450. doi:10.1016/j.jamda.2019.03.025 - DOI - PubMed
    1. Doraiswamy PM, Leon J, Cummings JL, Marin D, Neumann PJ. Prevalence and impact of medical comorbidity in Alzheimer’s disease. J Gerontol A Biol Sci Med Sci. 2002;57:M173–M177. doi:10.1093/gerona/57.3.m173 - DOI - PubMed
    1. Welsh TJ, Gladman JR, Gordon AL. The treatment of hypertension in people with dementia: a systematic review of observational studies. BMC Geriatr. 2014;14:19. doi:10.1186/1471-2318-14-19 - DOI - PMC - PubMed
    1. Goldstein FC, Levey AI, Steenland NK. High blood pressure and cognitive decline in mild cognitive impairment. J Am Geriatr Soc. 2013;61:67–73. doi:10.1111/jgs.12067 - DOI - PMC - PubMed

Publication types